|
Volume 270,
Number 9,
Issue of March 3, 1995 pp. 4619-4623
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Tenascin-C
Binds Heparin by Its Fibronectin Type III Domain Five
(Received for publication, October 20, 1994; and in revised form, December 22, 1994)
Peter
Weber,
Dieter
R.
Zimmermann
,
Kaspar H.
Winterhalter ,
Lloyd
Vaughan
Two sites on tenascin mediate interactions with
glycosaminoglycan chains of proteoglycans. One is situated on the
fibrinogen-like domain, whereas the other lies within the fibronectin
type III homology region (Aukhil, I., Joshi, P., Yan, Y. Z., and
Erickson, H. P.(1993) J. Biol. Chem. 268, 2542-2553.).
We now characterize the latter binding site more closely by means of
recombinant protein fragments derived from the type III homology region
of tenascin. Using a heparin-Sepharose column, we localize the second
heparin binding site to the fifth fibronectin type III domain. This is
confirmed in solid phase assays by incubation of fusion proteins with
biotin-labeled heparin. In addition, we demonstrate the binding of
heparan sulfate and dermatan sulfate to domain five. Molecular
modelling of this domain reveals a conserved heparin-binding motif that
we propose as the putative binding site. The fact, that different
glycosaminoglycans may bind to this domain, implies that different
classes of proteoglycans may in vivo compete for the same
site.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J.-H. Jang, J.-H. Hwang, C.-P. Chung, and P.-H. Choung
Identification and Kinetics Analysis of a Novel Heparin-binding Site (KEDK) in Human Tenascin-C
J. Biol. Chem.,
June 11, 2004;
279(24):
25562 - 25566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Phillips, L. Krushel, and K. Crossin
Domains of tenascin involved in glioma migration
J. Cell Sci.,
January 4, 1998;
111(8):
1095 - 1104.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Bennett, J. Bradshaw, T. Youngman, J. Rodgers, B. Greenfield, A. Aruffo, and P. S. Linsley
Deleted in Colorectal Carcinoma (DCC) Binds Heparin via Its Fifth Fibronectin Type III Domain
J. Biol. Chem.,
October 24, 1997;
272(43):
26940 - 26946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Clark, H. P. Erickson, and T. A. Springer
Tenascin Supports Lymphocyte Rolling
J. Cell Biol.,
May 5, 1997;
137(3):
755 - 765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Fischer, M Brown-Ludi, T Schulthess, and R Chiquet-Ehrismann
Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth
J. Cell Sci.,
January 7, 1997;
110(13):
1513 - 1522.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chung and H. Erickson
Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C
J. Cell Sci.,
January 6, 1997;
110(12):
1413 - 1419.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lethias, F. Elefteriou, G. Parsiegla, J.-Y. Exposito, and R. Garrone
Identification and Characterization of a Conformational Heparin-binding Site Involving Two Fibronectin Type III Modules of Bovine Tenascin-X
J. Biol. Chem.,
May 4, 2001;
276(19):
16432 - 16438.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|